文献速递神经肿瘤

氨基酸示踪剂PET显像在弥漫性低级别胶质瘤术前应用中的系统评价

Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications.
PubMed 文献 · Acta Neurochir (Wien) · 2018-05-24

该系统评价检索Medline、Cochrane图书馆和Embase数据库,从2137项符合条件的研究中纳入28项,评估氨基酸PET在疑似弥漫性低级别胶质瘤中的术前诊断和预后价值。结果显示氨基酸摄取增高在组织病理学证实的低级别胶质瘤中占25-92%、在高级别胶质瘤中占83-100%,部分非肿瘤性病变也可见摄取增高;诊断和预后价值的结果不一致。作者认为PET的预后价值限于低级别胶质瘤的组织学亚组分析,采用动态FET摄取参数的动力学分析时可能最强。

要点

  • 氨基酸PET摄取增高见于组织病理学证实的25-92%低级别胶质瘤和83-100%高级别胶质瘤,部分非肿瘤性病变也可见。
  • MRI疑似低级别胶质瘤的PET热点区域研究结果不一致,诊断价值难以解读。
  • PET预后价值及摄取比值与分子肿瘤状态的相关性结果相互矛盾。

核心结论

  • 作者认为PET的预后价值限于低级别胶质瘤的组织学亚组分析,采用动态FET摄取参数的动力学分析时可能最强。

研究设计与样本

  • 系统评价,系统检索Medline、Cochrane图书馆和Embase数据库,检索词为「PET」「低级别胶质瘤」「氨基酸示踪剂」及其同义词,从2137项符合条件的研究中纳入28项。

主要发现

  • 纳入研究一致报告氨基酸摄取(病灶/脑)增高,在随后组织病理学证实的低级别胶质瘤中占25-92%,在组织病理学证实的高级别胶质瘤中占83-100%,部分非肿瘤性病变也可见。
  • 报告MRI疑似低级别胶质瘤PET热点区域的研究未发现一致结果。
  • 关于疑似低级别胶质瘤PET预后价值及摄取比值与低级别胶质瘤分子肿瘤状态相关性的结果相互矛盾。
  • 该系统评价说明,呈现组水平数据而未校正已确立临床预后因素的预后研究存在困难,导致额外预后信息丢失。

关键数值与推荐

  • 氨基酸摄取增高在组织病理学证实的低级别胶质瘤中占25-92%,在组织病理学证实的高级别胶质瘤中占83-100%。

局限性

  • 该系统评价说明,呈现组水平数据而未校正已确立临床预后因素的预后研究存在困难,导致额外预后信息丢失。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Positron emission tomography (PET) imaging using amino acid tracers has in recent years become widely used in the diagnosis and prediction of disease course in diffuse low-grade gliomas (LGG). However, implications of preoperative PET for treatment and prognosis in this patient group have not been systematically studied. The aim of this systematic review was to evaluate the preoperative diagnostic and prognostic value of amino acid PET in suspected diffuse LGG. Medline, Cochrane Library, and Embase databases were systematically searched using keywords "PET," "low-grade glioma," and "amino acids tracers" with their respective synonyms. Out of 2137 eligible studies, 28 met the inclusion criteria. Increased amino acid uptake (lesion/brain) was consistently reported among included studies; in 25-92% of subsequently histopathology-verified LGG, in 83-100% of histopathology-verified HGG, and also in some non-neoplastic lesions. No consistent results were found in studies reporting hot spot areas on PET in MRI-suspected LGG. Thus, the diagnostic value of amino acid PET imaging in suspected LGG has proven difficult to interpret, showing clear overlap and inconsistencies among reported results. Similarly, the results regarding the prognostic value of PET in suspected LGG and the correlation between uptake ratios and the molecular tumor status of LGG were conflicting. This systematic review illustrates the difficulties with prognostic studies presenting data on group-level without adjustment for established clinical prognostic factors, leading to a loss of additional prognostic information. We conclude that the prognostic value of PET is limited to analysis of histological subgroups of LGG and is probably strongest when using kinetic analysis of dynamic FET uptake parameters.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Näslund O, Smits A, Förander P, et al. Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications. Acta Neurochir (Wien). 2018. PMID: 29797098. doi:10.1007/s00701-018-3563-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。